Annual EBITDA
$1.29B$199.71M-13.38%
Summary
- Current Value
- As of today, RPRX annual EBITDA is $1.29B, down -13.38% on
- Historical Performance
- RPRX annual EBITDA is down -11.09% over the past 3 years, and down -51.18% over the past 5 years
- All-Time High Comparison
- RPRX annual EBITDA is currently -51.18% below its historical high of $2.65B set on
- 3-Year Low Comparison
- RPRX annual EBITDA is +39.19% above its 3-year low of $928.56M reached on an earlier date
- Sector Comparison
- RPRX annual EBITDA is higher than 94.48% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $1.29B | -13.4% | -11.1% | -51.2% | +49.9% | |
| Quarterly EBITDA | $428.43M | -41.7% | +122.9% | -17.0% | -2.1% | |
| TTM EBITDA | $1.53B | -0.7% | +60.7% | -41.8% | +250.5% | |
| Price | $39.72 | +29.2% | +0.9% | -23.5% | – | |
| PE Ratio | 22.71 | +41.7% | -93.5% | +14.9% | – | |
| Annual Revenue | $2.26B | -3.9% | -1.1% | +24.8% | +37.0% | |
| Annual EPS | $1.91 | -24.5% | +28.0% | -70.2% | +99.6% | |
| Annual EBIT | $1.29B | -13.4% | -9.7% | -50.7% | +62.7% | |
| Annual Net Income | $1.33B | -21.7% | +7.2% | -45.9% | +75.4% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $1.49B | -13.4% | |
| 5Y | $1.62B | N/A | -20.1% |
| All | $2.65B | -51.2% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $928.56M | N/A | +39.2% |
| 5Y | $928.56M | +39.2% | |
| All | $791.08M | +63.4% |
EBITDA History
| Year | Value | Change |
|---|---|---|
| $1.29B | -13.4% | |
| $1.49B | +60.7% | |
| $928.56M | -36.1% | |
| $1.45B | -10.2% | |
| $1.62B | -38.9% |
| Year | Value | Change |
|---|---|---|
| $2.65B | +89.4% | |
| $1.40B | +43.7% | |
| $972.96M | +23.0% | |
| $791.08M | -8.3% | |
| $862.44M | - |
FAQ
What is the current annual EBITDA of RPRX?
As of today, RPRX annual EBITDA is $1.29B
What is 1-year change in RPRX annual EBITDA?
RPRX annual EBITDA is down -13.38% year-over-year
What is 3-year change in RPRX annual EBITDA?
RPRX annual EBITDA is down -11.09% over the past 3 years
How far is RPRX annual EBITDA from its all-time high?
RPRX annual EBITDA is currently -51.18% below its historical high of $2.65B set on December 31, 2019
How does RPRX annual EBITDA rank versus sector peers?
RPRX annual EBITDA is higher than 94.48% of companies in Healthcare sector
When is RPRX next annual earnings release?
The next annual earnings release for RPRX is on
Quarterly EBITDA
$428.43M$218.63M+104.21%
Summary
- Current Value
- As of today, RPRX quarterly EBITDA is $428.43M, up +104.21% on
- Historical Performance
- RPRX quarterly EBITDA is down -41.72% year-over-year, and up +122.90% over the past 3 years
- All-Time High Comparison
- RPRX quarterly EBITDA is currently -67.97% below its historical high of $1.34B set on
- 3-Year Low Comparison
- RPRX quarterly EBITDA is +680.74% above its 3-year low of -$73.77M reached on
- Sector Comparison
- RPRX quarterly EBITDA is higher than 94.67% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $428.43M | +104.2% | -41.7% | +122.9% | -17.0% | |
| Annual EBITDA | $1.29B | – | -13.4% | -11.1% | -51.2% | |
| TTM EBITDA | $1.53B | -16.7% | -0.7% | +60.7% | -41.8% | |
| Price | $39.72 | +9.8% | +29.2% | +0.9% | -23.5% | |
| PE Ratio | 22.71 | +9.8% | +41.7% | -93.5% | +14.9% | |
| Quarterly Revenue | $609.29M | +5.3% | +7.9% | +6.3% | +13.2% | |
| Quarterly EPS | $0.67 | +838.5% | -45.2% | +104.9% | -15.3% | |
| Quarterly EBIT | $427.16M | +103.6% | -41.9% | +122.2% | -16.3% | |
| Quarterly Net Income | $444.21M | +390.1% | -44.9% | +101.5% | -28.8% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $534.18M | -19.8% | |
| 3Y | $735.07M | -41.7% | |
| 5Y | $750.68M | -42.9% | |
| All | $1.34B | -68.0% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $209.80M | +104.2% | |
| 3Y | -$73.77M | +680.7% | |
| 5Y | -$73.77M | +680.7% | |
| All | -$73.77M | +680.7% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of RPRX?
As of today, RPRX quarterly EBITDA is $428.43M
What is RPRX quarterly EBITDA most recent change?
RPRX quarterly EBITDA was up +104.21% on September 30, 2025
What is 1-year change in RPRX quarterly EBITDA?
RPRX quarterly EBITDA is down -41.72% year-over-year
How far is RPRX quarterly EBITDA from its all-time high?
RPRX quarterly EBITDA is currently -67.97% below its historical high of $1.34B set on December 31, 2019
How does RPRX quarterly EBITDA rank versus sector peers?
RPRX quarterly EBITDA is higher than 94.67% of companies in Healthcare sector
When is RPRX next earnings release?
The next earnings release for RPRX is on
TTM EBITDA
$1.53B$306.64M-16.66%
Summary
- Current Value
- As of today, RPRX TTM EBITDA is $1.53B, down -16.66% on
- Historical Performance
- RPRX TTM EBITDA is down -0.68% year-over-year, and up +60.67% over the past 3 years
- All-Time High Comparison
- RPRX TTM EBITDA is currently -42.31% below its historical high of $2.66B set on
- 3-Year Low Comparison
- RPRX TTM EBITDA is +65.17% above its 3-year low of $928.39M reached on an earlier date
- Sector Comparison
- RPRX TTM EBITDA is higher than 94.58% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $1.53B | -16.7% | -0.7% | +60.7% | -41.8% | |
| Annual EBITDA | $1.29B | – | -13.4% | -11.1% | -51.2% | |
| Quarterly EBITDA | $428.43M | +104.2% | -41.7% | +122.9% | -17.0% | |
| Price | $39.72 | +9.8% | +29.2% | +0.9% | -23.5% | |
| PE Ratio | 22.71 | +9.8% | +41.7% | -93.5% | +14.9% | |
| TTM Revenue | $2.35B | +1.9% | +3.7% | +4.6% | +17.1% | |
| TTM EPS | $1.75 | -23.9% | -31.6% | +50.7% | -71.2% | |
| TTM EBIT | $1.53B | -16.7% | -0.8% | +62.5% | -41.4% | |
| TTM Net Income | $1.30B | -21.8% | -24.0% | +45.6% | -53.2% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.90B | -19.3% | |
| 3Y | $1.90B | -19.3% | |
| 5Y | $1.90B | -19.3% | |
| All | $2.66B | -42.3% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.29B | N/A | +18.7% |
| 3Y | $928.39M | N/A | +65.2% |
| 5Y | $928.39M | +65.2% | |
| All | $437.50M | +250.5% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of RPRX?
As of today, RPRX TTM EBITDA is $1.53B
What is RPRX TTM EBITDA most recent change?
RPRX TTM EBITDA was down -16.66% on September 30, 2025
What is 1-year change in RPRX TTM EBITDA?
RPRX TTM EBITDA is down -0.68% year-over-year
How far is RPRX TTM EBITDA from its all-time high?
RPRX TTM EBITDA is currently -42.31% below its historical high of $2.66B set on June 30, 2020
How does RPRX TTM EBITDA rank versus sector peers?
RPRX TTM EBITDA is higher than 94.58% of companies in Healthcare sector
When is RPRX next earnings release?
The next earnings release for RPRX is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- RPRX Official Website www.royaltypharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1802768/000180276825000114/0001802768-25-000114-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1802768/000180276825000010/0001802768-25-000010-index.htm
- RPRX Profile on Yahoo Finance finance.yahoo.com/quote/RPRX
- RPRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rprx